Nucleic acid vaccines: prospects for non-viral delivery of mRNA vaccines
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Nucleic acid vaccines: prospects for non-viral delivery of mRNA vaccines
Authors
Keywords
-
Journal
Expert Opinion on Drug Delivery
Volume 11, Issue 6, Pages 885-899
Publisher
Informa Healthcare
Online
2014-03-26
DOI
10.1517/17425247.2014.901308
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A phase IB study on intravenous synthetic mRNA electroporated dendritic cell immunotherapy in pretreated advanced melanoma patients
- (2013) S. Wilgenhof et al. ANNALS OF ONCOLOGY
- Natural antibodies to nucleic acids
- (2013) V. N. Buneva et al. BIOCHEMISTRY-MOSCOW
- Efficient Generation of Human iPSCs by a Synthetic Self-Replicative RNA
- (2013) Naohisa Yoshioka et al. Cell Stem Cell
- Alphavirus Genome Delivery Occurs Directly at the Plasma Membrane in a Time- and Temperature-Dependent Process
- (2013) R. Vancini et al. JOURNAL OF VIROLOGY
- RNA-Based Vaccination: Sending a Strong Message
- (2013) David B. Weiner MOLECULAR THERAPY
- Modified mRNA directs the fate of heart progenitor cells and induces vascular regeneration after myocardial infarction
- (2013) Lior Zangi et al. NATURE BIOTECHNOLOGY
- In Vivo Messenger RNA Introduction into the Central Nervous System Using Polyplex Nanomicelle
- (2013) Satoshi Uchida et al. PLoS One
- Accelerating Next-Generation Vaccine Development for Global Disease Prevention
- (2013) W. C. Koff et al. SCIENCE
- RNA: The new revolution in nucleic acid vaccines
- (2013) Andrew J. Geall et al. SEMINARS IN IMMUNOLOGY
- Challenges and advances towards the rational design of mRNA vaccines
- (2013) Charlotte Pollard et al. TRENDS IN MOLECULAR MEDICINE
- mRNA
- (2013) Sandra Van Lint et al. Human Vaccines & Immunotherapeutics
- A novel, disruptive vaccination technology
- (2013) Karl-Josef Kallen et al. Human Vaccines & Immunotherapeutics
- Rapidly produced SAM® vaccine against H7N9 influenza is immunogenic in mice
- (2013) Armin Hekele et al. Emerging Microbes & Infections
- Preclinical Evaluation of TriMix and Antigen mRNA-Based Antitumor Therapy
- (2012) S. Van Lint et al. CANCER RESEARCH
- Regulation of eukaryotic gene expression by the untranslated gene regions and other non-coding elements
- (2012) Lucy W. Barrett et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Lack of Interference with Immunogenicity of a Chimeric Alphavirus Replicon Particle-Based Influenza Vaccine by Preexisting Antivector Immunity
- (2012) Yasushi Uematsu et al. Clinical and Vaccine Immunology
- A DNA-Based Candidate HIV Vaccine Delivered viaIn VivoElectroporation Induces CD4 Responses toward the α4β7-Binding V2 Loop of HIV gp120 in Healthy Volunteers
- (2012) Jakub Kopycinski et al. Clinical and Vaccine Immunology
- Viral and Non-Viral Approaches for Transient Delivery of mRNA and Proteins
- (2012) Juliane W. Schott et al. CURRENT GENE THERAPY
- Highly potent mRNA based cancer vaccines represent an attractive platform for combination therapies supporting an improved therapeutic effect
- (2012) Mariola Fotin-Mleczek et al. JOURNAL OF GENE MEDICINE
- A Sendai Virus-Derived RNA Agonist of RIG-I as a Virus Vaccine Adjuvant
- (2012) L. Martínez-Gil et al. JOURNAL OF VIROLOGY
- In Vivo Gene Delivery by Nonviral Vectors: Overcoming Hurdles?
- (2012) Yuan Zhang et al. MOLECULAR THERAPY
- Systemic Delivery of Modified mRNA Encoding Herpes Simplex Virus 1 Thymidine Kinase for Targeted Cancer Gene Therapy
- (2012) Yuhua Wang et al. MOLECULAR THERAPY
- Type I IFN Counteracts the Induction of Antigen-Specific Immune Responses by Lipid-Based Delivery of mRNA Vaccines
- (2012) Charlotte Pollard et al. MOLECULAR THERAPY
- Viral immune modulators perturb the human molecular network by common and unique strategies
- (2012) Andreas Pichlmair et al. NATURE
- Protective efficacy of in vitro synthesized, specific mRNA vaccines against influenza A virus infection
- (2012) Benjamin Petsch et al. NATURE BIOTECHNOLOGY
- A live, impaired-fidelity coronavirus vaccine protects in an aged, immunocompromised mouse model of lethal disease
- (2012) Rachel L Graham et al. NATURE MEDICINE
- Intradermal Electroporation of Naked Replicon RNA Elicits Strong Immune Responses
- (2012) Daniel X. Johansson et al. PLoS One
- Nonviral delivery of self-amplifying RNA vaccines
- (2012) A. J. Geall et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Developing mRNA-vaccine technologies
- (2012) Thomas Schlake et al. RNA Biology
- RNA-based vaccines
- (2012) Jeffrey B. Ulmer et al. VACCINE
- Clinical Applications of DNA Vaccines: Current Progress
- (2011) B. Ferraro et al. CLINICAL INFECTIOUS DISEASES
- Tumor vaccination using messenger RNA: prospects of a future therapy
- (2011) Sebastian Kreiter et al. CURRENT OPINION IN IMMUNOLOGY
- mRNA vaccination as a safe approach for specific protection from type I allergy
- (2011) Richard Weiss et al. Expert Review of Vaccines
- Pathogen Recognition by the Innate Immune System
- (2011) Himanshu Kumar et al. INTERNATIONAL REVIEWS OF IMMUNOLOGY
- In Vitroandin VivomRNA Delivery Using Lipid-Enveloped pH-Responsive Polymer Nanoparticles
- (2011) Xingfang Su et al. MOLECULAR PHARMACEUTICS
- Engineering Dendritic Cells to Enhance Cancer Immunotherapy
- (2011) Jeanette E Boudreau et al. MOLECULAR THERAPY
- Single-particle Tracking as a Quantitative Microscopy-based Approach to Unravel Cell Entry Mechanisms of Viruses and Pharmaceutical Nanoparticles
- (2011) Nadia Ruthardt et al. MOLECULAR THERAPY
- Enhancement of dendritic cells transfection in vivo and of vaccination against B16F10 melanoma with mannosylated histidylated lipopolyplexes loaded with tumor antigen messenger RNA
- (2011) Federico Perche et al. Nanomedicine-Nanotechnology Biology and Medicine
- Cancer immunotherapy comes of age
- (2011) Ira Mellman et al. NATURE
- Expression of therapeutic proteins after delivery of chemically modified mRNA in mice
- (2011) Michael S D Kormann et al. NATURE BIOTECHNOLOGY
- PEGylation Improves Nanoparticle Formation and Transfection Efficiency of Messenger RNA
- (2011) Senta Üzgün et al. PHARMACEUTICAL RESEARCH
- In Vivo Electroporation Enhances the Immunogenicity of an HIV-1 DNA Vaccine Candidate in Healthy Volunteers
- (2011) Sandhya Vasan et al. PLoS One
- Protein expression from exogenous mRNA: Uptake by receptor-mediated endocytosis and trafficking via the lysosomal pathway
- (2011) Christina Lorenz et al. RNA Biology
- Particle size and activation threshold: a new dimension of danger signaling
- (2010) L. Rettig et al. BLOOD
- Intranodal Vaccination with Naked Antigen-Encoding RNA Elicits Potent Prophylactic and Therapeutic Antitumoral Immunity
- (2010) S. Kreiter et al. CANCER RESEARCH
- Pattern Recognition Receptors and Inflammation
- (2010) Osamu Takeuchi et al. CELL
- Highly Efficient Reprogramming to Pluripotency and Directed Differentiation of Human Cells with Synthetic Modified mRNA
- (2010) Luigi Warren et al. Cell Stem Cell
- Recognition of viruses by cytoplasmic sensors
- (2010) Courtney Wilkins et al. CURRENT OPINION IN IMMUNOLOGY
- Immunologic Basis of Vaccine Vectors
- (2010) Margaret A. Liu IMMUNITY
- DNA vaccines: an historical perspective and view to the future
- (2010) Margaret A. Liu IMMUNOLOGICAL REVIEWS
- Lipid-mediated delivery of RNA is more efficient than delivery of DNA in non-dividing cells
- (2010) S. Zou et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Breaking down the barriers: siRNA delivery and endosome escape
- (2010) M. Dominska et al. JOURNAL OF CELL SCIENCE
- Messenger RNA-based Vaccines With Dual Activity Induce Balanced TLR-7 Dependent Adaptive Immune Responses and Provide Antitumor Activity
- (2010) Mariola Fotin-Mleczek et al. JOURNAL OF IMMUNOTHERAPY
- Intradermal Vaccinations With RNA Coding for TAA Generate CD8+ and CD4+ Immune Responses and Induce Clinical Benefit in Vaccinated Patients
- (2010) Susanne M Rittig et al. MOLECULAR THERAPY
- Rational design of cationic lipids for siRNA delivery
- (2010) Sean C Semple et al. NATURE BIOTECHNOLOGY
- Lipid-like materials for low-dose, in vivo gene silencing
- (2010) K. T. Love et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Role of 5′- and 3′-untranslated regions of mRNAs in human diseases
- (2009) Sangeeta Chatterjee et al. BIOLOGY OF THE CELL
- Direct Injection of Protamine-protected mRNA: Results of a Phase 1/2 Vaccination Trial in Metastatic Melanoma Patients
- (2009) Benjamin Weide et al. JOURNAL OF IMMUNOTHERAPY
- Knocking down barriers: advances in siRNA delivery
- (2009) Kathryn A. Whitehead et al. NATURE REVIEWS DRUG DISCOVERY
- Randomized, double-blind, Phase 1 trial of an alphavirus replicon vaccine for cytomegalovirus in CMV seronegative adult volunteers
- (2009) David I. Bernstein et al. VACCINE
- Therapeutic and prophylactic applications of alphavirus vectors
- (2008) Gregory J. Atkins et al. EXPERT REVIEWS IN MOLECULAR MEDICINE
- Phenotypic and Functional Analysis of Dendritic Cells and Clinical Outcome in Patients With High-Risk Melanoma Treated With Adjuvant Granulocyte Macrophage Colony-Stimulating Factor
- (2008) Adil I. Daud et al. JOURNAL OF CLINICAL ONCOLOGY
- Results of the First Phase I/II Clinical Vaccination Trial With Direct Injection of mRNA
- (2008) Benjamin Weide et al. JOURNAL OF IMMUNOTHERAPY
- Design opportunities for actively targeted nanoparticle vaccines
- (2008) Tarek M Fahmy et al. Nanomedicine
- DNA vaccines: ready for prime time?
- (2008) Michele A. Kutzler et al. NATURE REVIEWS GENETICS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started